FDA Clarifies Policies for Compounders as National GLP-1 Supply Begins to Stabilize
Audience: Industry October 2, 2024 — The U.S. Food and Drug Administration has determined the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, has been resolved. Tirzepatide injection has been in shortage since 2022…